Skip to content

PolitiKit

Lobbying by Abbott Laboratories Co.: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.

← Lobbying

Corporation

Abbott Laboratories Co.

Meetings this Parliament
23
With MPs
0
Since Nov 2021
41
Active registrations
1

Most recent reported meeting: Sep 16, 2026.

Registrations in effect

In-house (corporation) In effect since Sep 16, 2026

Filed by Luz Herrera, General Manager - Canada, Abbott Diabetes Care

Lobbyists

  • Andrew Bowles · Director – Government Affairs, Canada
  • Katie Fretz · Manager, Stakeholder Relations
  • Luz Herrera · General Manager - Canada, Abbott Diabetes Care
  • Maria Karounis · General Manager - Canada, Abbott Nutrition
  • Sophia Shin · Manager, Market Access

Institutions they may lobby: Agriculture and Agri-Food Canada (AAFC), CUSMA Secretariat, Correctional Service of Canada (CSC), Environment and Climate Change Canada (ECCC), Finance Canada (FIN), Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Indigenous Services Canada (ISC), Innovation, Science and Economic Development Canada (ISED), Intergovernmental Affairs Secretariat (IGA), Privy Council Office (PCO), Public Health Agency of Canada (PHAC), Public Services and Procurement Canada (PSPC), Senate of Canada, Treasury Board Of Canada Secretariat (TBS), Veterans Affairs Canada (VAC)

What they're lobbying on (4)
  • Engaging with the government regarding Canada's Biomanufacturing and Life Sciences Strategy and artificial intelligence strategy in relation to healthcare.
  • Engaging government with respect to the importance of the Canada/US/Mexico Free Trade Agreement (CUSMA) to the life sciences sector & ensuring open supply chains to trade partners and tariff-free access to medical devices.
  • Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems.
  • Working with Food, Health & Consumer Products (FHCP) Infant Formula Council on the proposed regulatory modernization of Food & Drug Regulations Divisions 24 & 25.

Registration 955225-5310-36. Look it up in the official Registry

Reported meetings

Spreadsheet

Filed by Luz Herrera (30), Matthew Harris (6), Philippe Busque (5).

  • Reported by Luz Herrera · In-house (corporation)

    • Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    Engaging with the government regarding Canada's Biomanufacturing and Life Sciences Strategy and artificial intelligence strategy in relation to healthcare.

    Official report

  • Reported by Luz Herrera · In-house (corporation)

    • Victoria Perak · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    Engaging with the government regarding Canada's Biomanufacturing and Life Sciences Strategy and artificial intelligence strategy in relation to healthcare.

    Official report

  • Reported by Luz Herrera · In-house (corporation)

    • Niloo Boroun · Director of International Policy, Finance Canada (FIN)
    Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems. Read more

    Engaging government with respect to the importance of the Canada/US/Mexico Free Trade Agreement (CUSMA) to the life sciences sector & ensuring open supply chains to trade partners and tariff-free access to medical devices.

    Official report

  • Reported by Luz Herrera · In-house (corporation)

    • Kabisan Thanendran · Policy Advisor, Public Services and Procurement Canada (PSPC)
    Engaging government with respect to the importance of the Canada/US/Mexico Free Trade Agreement (CUSMA) to the life sciences sector & ensuring open supply chains to trade partners and tariff-free access to medical devices. Read more

    Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems.

    Official report

  • Reported by Luz Herrera · In-house (corporation)

    • Roy Karam · Advisor, Economic and Health System Policy, Health Canada (HC)
    Engaging government with respect to the importance of the Canada/US/Mexico Free Trade Agreement (CUSMA) to the life sciences sector & ensuring open supply chains to trade partners and tariff-free access to medical devices. Read more

    Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems.

    Official report

  • Reported by Luz Herrera · In-house (corporation)

    • Roy Karam · Advisor, Economic and Health System Policy, Health Canada (HC)
    Engaging government with respect to the importance of the Canada/US/Mexico Free Trade Agreement (CUSMA) to the life sciences sector & ensuring open supply chains to trade partners and tariff-free access to medical devices. Read more

    Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems.

    Official report

  • Reported by Luz Herrera · In-house (corporation)

    • Lisa Xie · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    • Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems. Read more

    Engaging government with respect to the importance of the Canada/US/Mexico Free Trade Agreement (CUSMA) to the life sciences sector & ensuring open supply chains to trade partners and tariff-free access to medical devices.

    Official report

  • Reported by Luz Herrera · In-house (corporation)

    • John Ivison · Administrative Officer, Correctional Service of Canada (CSC)
    • Bassem Guirguis · National Pharmacist, Correctional Service of Canada (CSC)
    Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems. Read more

    Official report

  • Reported by Luz Herrera · In-house (corporation)

    • John Ivison · Administrative Officer, Correctional Service of Canada (CSC)
    • Bassem Guirguis · National Pharmacist, Correctional Service of Canada (CSC)
    Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems. Read more

    Official report

  • Reported by Luz Herrera · In-house (corporation)

    • Jessica Fullerton · Director of Policy to the Minister of International Trade, Global Affairs Canada (GAC)
    Engaging government with respect to the importance of the Canada/US/Mexico Free Trade Agreement (CUSMA) to the life sciences sector & ensuring open supply chains to trade partners and tariff-free access to medical devices. Read more

    Official report

  • Reported by Luz Herrera · In-house (corporation)

    • Jade Malette · Chief of Staff, Health Canada (HC)
    • Justine Frame · Senior Policy Advisor, Health Canada (HC)
    Engaging government with respect to the importance of CUSMA to the life sciences sector. Read more

    Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems.

    Official report

  • Reported by Luz Herrera · In-house (corporation)

    • Carlos Vanderloo · Minister-Counsellor, Global Affairs Canada (GAC)
    • Kaitlyn Pritchard · Trade Program Manager, Global Affairs Canada (GAC)
    Engaging government with respect to the importance of CUSMA to the life sciences sector.

    Official report

  • Reported by Luz Herrera · In-house (corporation)

    • Madeleine Féquière · Consul General of Canada in Chicago, United States, Global Affairs Canada (GAC)
    • Cory Olishansky · Consul and Trade Commissioner, Global Affairs Canada (GAC)
    • Julien Rosan · Life Sciences Trade Commissioner, Global Affairs Canada (GAC)
    Engaging government with respect to the importance of CUSMA to the life sciences sector.

    Official report

  • Reported by Luz Herrera · In-house (corporation)

    • Miro Froehlich · Director of Policy, Privy Council Office (PCO)
    • Nasser Haidar · Senior Policy Advisor, Intergovernmental Affairs Secretariat (IGA)
    Engaging government with respect to the importance of CUSMA to the life sciences sector.

    Official report

  • Reported by Luz Herrera · In-house (corporation)

    • John Ivison · Administrative Officer, Correctional Service of Canada (CSC)
    • Bassem Guirguis · National Pharmacist, Correctional Service of Canada (CSC)
    Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems. Read more

    Official report

  • Reported by Luz Herrera · In-house (corporation)

    • Gabrielle Tessier · Deputy Director, Events, Finance Canada (FIN)
    Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems. Read more

    Official report

  • Reported by Luz Herrera · In-house (corporation)

    • Gabrielle Tessier · Deputy Director, Events, Finance Canada (FIN)
    Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems. Read more

    Official report

  • Reported by Luz Herrera · In-house (corporation)

    • Gabrielle Tessier · Deputy Director, Events, Finance Canada (FIN)
    Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems. Read more

    Official report

  • Reported by Luz Herrera · In-house (corporation)

    • John Ivison · Administrative Officer, Correctional Service of Canada (CSC)
    • Bassem Guirguis · National Pharmacist, Correctional Service of Canada (CSC)
    Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products. Read more

    Official report

  • Reported by Luz Herrera · In-house (corporation)

    • Marnie Mitchel · Senior Manager, Indigenous Services Canada (ISC)
    Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products. Read more

    Official report

  • Reported by Luz Herrera · In-house (corporation)

    • Mark Szeto · Policy Analyst, Indigenous Services Canada (ISC)
    • Ryan Redecopp · Program Officer, Indigenous Services Canada (ISC)
    Engaging across Government regarding the public reimbursement of Abbott's FreeStyle Libre brand products.

    Official report

  • Reported by Luz Herrera · In-house (corporation)

    • Mark Szeto · Policy Analyst, Indigenous Services Canada (ISC)
    • Ryan Redecopp · Program Officer, Indigenous Services Canada (ISC)
    Engaging across Government regarding the public reimbursement of Abbott's FreeStyle Libre brand products.

    Official report

  • Reported by Luz Herrera · In-house (corporation)

    • Mark Szeto · Policy Analyst, Indigenous Services Canada (ISC)
    • Ryan Redecopp · Program Officer, Indigenous Services Canada (ISC)
    Engaging across Government regarding the public reimbursement of Abbott's FreeStyle Libre brand products.

    Official report

  • Reported by Luz Herrera · In-house (corporation)

    • Mark Szeto · Policy Analyst, Indigenous Services Canada (ISC)
    • Ryan Redecopp · Program Officer, Indigenous Services Canada (ISC)
    Engaging across Government regarding the public reimbursement of Abbott's FreeStyle Libre brand products.

    Official report

  • Reported by Luz Herrera · In-house (corporation)

    • Mark Szeto · Policy Analyst, Indigenous Services Canada (ISC)
    • Ryan Redecopp · Program Officer, Indigenous Services Canada (ISC)
    Engaging across Government regarding the public reimbursement of Abbott's FreeStyle Libre brand products.

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.